<H1>Chapter DOI: 10.1208/aapsj070359<br/>Cited-By Count: 20</H1><table border="1" width="30%"><tr><td>Total References</td><td>61</td></tr><tr><td>Springer references</td><td>5</td></tr><tr><td>Non Springer references</td><td>56</td></tr><tr><td>BibStructured Count</td><td width="10%">61</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>46</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>4</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>4</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Koob GF. Neurobiology of addiction. Toward the development of new therapies.<Emphasis Type="Italic">Ann NY Acad Sci.</Emphasis> 2000;909:170&#8211;185.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.2000.tb06682.x>10.1111/j.1749-6632.2000.tb06682.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Weiss F., Koob GF. Drug addiction: functional neurotoxicity of the brain reward systems.<Emphasis Type="Italic">Neurotoxic Res.</Emphasis> 2001;3:145&#8211;156.</td><td><a href=http://dx.doi.org/10.1007/BF03033235>10.1007/BF03033235</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Melichar JK, Daglish MRC, Nutt DJ. Addiction and withdrawalcurrent views.<Emphasis Type="Italic">Curr Opin Pharmacol.</Emphasis> 2001;1:84&#8211;90.</td><td><a href=http://dx.doi.org/10.1016/S1471-4892(01)00011-X>10.1016/S1471-4892(01)00011-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status.<Emphasis Type="Italic">Trends Neurosci.</Emphasis> 1999;22:521&#8211;527.</td><td><a href=http://dx.doi.org/10.1016/S0166-2236(99)01447-2>10.1016/S0166-2236(99)01447-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Di Chiana G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 1995;38:95&#8211;137.</td><td><a href=http://dx.doi.org/10.1016/0376-8716(95)01118-I>10.1016/0376-8716(95)01118-I</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Johanson C-E, Fischman MW. The pharmacology of cocaine related to its abuse.<Emphasis Type="Italic">Pharmacol Rev.</Emphasis> 1989;41:3&#8211;52.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Blaine JD, Ling W. Psychopharm acologic treatment of cocaine dependence.<Emphasis Type="Italic">Psychopharmacol Bull.</Emphasis> 1992;28:11&#8211;14.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibBook</td><td>Substance Abuse and Mental Health Services Administration, Office of Applied Studies,<Emphasis Type="Italic">Preliminary estimates from the 1992 Household Survey on Drug Abuse</Emphasis>.<Emphasis Type="Italic">Advance Report No. 3</Emphasis>. Washington, DC: US Department of Health and Human Services, Public Health Service, June 1993.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Cregler LL, Herbert M. Medical complications of cocaine abuse.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1986;315:1495&#8211;1500.</td><td><a href=http://dx.doi.org/10.1056/NEJM198612043152327>10.1056/NEJM198612043152327</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Des Jarlais DC, Friedman SR. AIDS and i.v. drug use.<Emphasis Type="Italic">Science.</Emphasis> 1989;245:578&#8211;579.</td><td><a href=http://dx.doi.org/10.1126/science.2762809>10.1126/science.2762809</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibChapter</td><td>Lee JH, Bennett G. Substaance abuse in adulthood. In: Bennett G, Woolf D, ed.<Emphasis Type="Italic">Substance Abuse: Pharmacologic, Developmental and Clinical Perspectives</Emphasis>. Albany: Delman Publishing, 1991:157&#8211;170.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibChapter</td><td>Walsh SL. Behavioral pharmacology of cocaine. In: Tarter RE, Ammerman RT, Ott PJ, eds.<Emphasis Type="Italic">Handbook of Substance Abuse: Neurobehavioral Pharmacology</Emphasis>: New York: Plenum; 1998:187&#8211;200.</td><td><a href=http://dx.doi.org/10.1007/978-1-4757-2913-9_12>10.1007/978-1-4757-2913-9_12</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Mendelson JH, Mello NK. Management of cocaine abuse and dependence.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1996;334:965&#8211;972.</td><td><a href=http://dx.doi.org/10.1056/NEJM199604113341507>10.1056/NEJM199604113341507</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibChapter</td><td>Gorelick DA. Pharmacologic interventions for cocaine, crack, and other stimulant addiction. In: Graham AW, Schultz TK, eds.,<Emphasis Type="Italic">Principles of Addiction Medicine</Emphasis>. Chevy Chase, MD. American Society of Addiction Medicine; 2003:89&#8211;111.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Gorelick DA, Gardner EL, Xi Z-X. Agents in the development for the management of cocaine abuse.<Emphasis Type="Italic">Drugs.</Emphasis> 2004;64:1547&#8211;1573.</td><td><a href=http://dx.doi.org/10.2165/00003495-200464140-00004>10.2165/00003495-200464140-00004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Leiderman DB, Shoptaw S, Montgomery A, et al. Cocaine rapid efficacy screening trial (CREST). A paradigm for the controlled evaluation of candidate medications for cocaine dependence.<Emphasis Type="Italic">Addiction.</Emphasis> 2005;100:1&#8211;11.</td><td><a href=http://dx.doi.org/10.1111/j.1360-0443.2005.00988.x>10.1111/j.1360-0443.2005.00988.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Winhusen TM, Somoza EC, Harrer JM, et al. A placebo-controlled screening trial of tiagabine, sertaline and donepezil as cocaine dependence treatment.<Emphasis Type="Italic">Addiction.</Emphasis> 2005;100:68&#8211;77.</td><td><a href=http://dx.doi.org/10.1111/j.1360-0443.2005.00992.x>10.1111/j.1360-0443.2005.00992.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Gonzalez G, Sevarino K, Sofuoglu M, et al. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study.<Emphasis Type="Italic">Addiction.</Emphasis> 2003;98:1625&#8211;1632</td><td><a href=http://dx.doi.org/10.1046/j.1360-0443.2003.00544.x>10.1046/j.1360-0443.2003.00544.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.<Emphasis Type="Italic">Arch Gen Psychiatry</Emphasis> 2004;61:264&#8211;272.</td><td><a href=http://dx.doi.org/10.1001/archpsyc.61.3.264>10.1001/archpsyc.61.3.264</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Houtsmuller EJ, Notes LD, Newton T, et al. Transdermal selegiline and intravenous cocaine: safety and interactions.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 2004;172:31&#8211;40.</td><td><a href=http://dx.doi.org/10.1007/s00213-003-1616-6>10.1007/s00213-003-1616-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Shoptaw S, Yang X, Rotheram-Fuller EJ, et al. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.<Emphasis Type="Italic">J Clin Psychiatry.</Emphasis> 2003;64:1440&#8211;1448.</td><td><a href=http://dx.doi.org/10.4088/JCP.v64n1207>10.4088/JCP.v64n1207</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Kampman KM, Pettinati H, Lynch KG, et al. A pilot trial of topiramate for the treatment of cocaine dependence.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 2004;75:233&#8211;240.</td><td><a href=http://dx.doi.org/10.1016/j.drugalcdep.2004.03.008>10.1016/j.drugalcdep.2004.03.008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Kampman KM, Volpicelli JR, Mulvaney F, et al. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 2001;63:69&#8211;78.</td><td><a href=http://dx.doi.org/10.1016/S0376-8716(00)00193-9>10.1016/S0376-8716(00)00193-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Hoffman JA III, Caudill BD III, Koman JJ III, Luckey JW, Flynn PM, Hubbard RL. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure.<Emphasis Type="Italic">J Addict Dis.</Emphasis> 1994;13:115&#8211;128.</td><td><a href=http://dx.doi.org/10.1300/J069v13n04_01>10.1300/J069v13n04_01</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Cashman JR. Biocatalysts in detoxication of drug of abuse.<Emphasis Type="Italic">NIDA Res Monogr.</Emphasis> 1997;173:225&#8211;258.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Carrera MRA, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Suppression of psychoactive effects of cocaine by active immunization.<Emphasis Type="Italic">Nature.</Emphasis> 1995;378:727&#8211;730.</td><td><a href=http://dx.doi.org/10.1038/378727a0>10.1038/378727a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Carrera MRA, Ashley JA, zhou B, Wirsching P, Koob GF, Janda KD. Cocaine vaccines: antibody protection against relapse in a rat model.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2000;97:6202&#8211;6206.</td><td><a href=http://dx.doi.org/10.1073/pnas.97.11.6202>10.1073/pnas.97.11.6202</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Carrera MRA, Ashley JA, Wirsching P, Koob GF, Janda KD. A second-generation vaccine protects against the psychoactive effects of cocaine.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2001;98:1988&#8211;1992.</td><td><a href=http://dx.doi.org/10.1073/pnas.98.4.1988>10.1073/pnas.98.4.1988</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Fox BS, Kantak KM, Edwards MA, et al. Efficacy of a therapeutic cocaine vaccine in rodent models.<Emphasis Type="Italic">Nat Med.</Emphasis> 1996;2:11129&#8211;11132.</td><td><a href=http://dx.doi.org/10.1038/nm1096-1129>10.1038/nm1096-1129</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, Author_FamilyName_1, VolumeID, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, Fox BS. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.<Emphasis Type="Italic">Psychopharmacology (Berl.)</Emphasis> 2000;148:251&#8211;262.</td><td><a href=http://dx.doi.org/10.1007/s002130050049>10.1007/s002130050049</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Landry DW, Zhao K, Yang GX-P, Glickman M, Georgiadis TM. Antibody-catalyzed degradation of cocaine.<Emphasis Type="Italic">Science.</Emphasis> 1993;259:1899&#8211;1901.</td><td><a href=http://dx.doi.org/10.1126/science.8456315>10.1126/science.8456315</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Cashman JR, Berkman CE, Underiner GE. Catalytic antibodies that hydrolyze (&#8211;)-cocaine obtained by a high-throughput procedure.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;293:952&#8211;961.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Yang G, Chun J, Arakawa-Uramoto H, et al. Anti-cocaine catalytic antibodies: a synthetic approach to improved antibody diversity.<Emphasis Type="Italic">J Am Chem. Soc.</Emphasis> 1996;118:5880&#8211;5890.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1021/ja953077+>10.1021/ja953077+</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Author_FamilyName_1, Year, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Baird TJ, Deng S-X, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;295:1127&#8211;1134.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Matsushita M, Hoffman TZ, Ashley JA, Zhou B, Wirsching P, Janda KD. Cocaine catalytic antibodies: the primary importance of linker effects.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2001;11:87&#8211;90.</td><td><a href=http://dx.doi.org/10.1016/S0960-894X(00)00659-4>10.1016/S0960-894X(00)00659-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Isomura S., Hoffman TZ, Wirsching P, Janda KD. Synthesis, properties, and reactivity of cocaine benzoylthioester possessing the cocaine absolute configuration.<Emphasis Type="Italic">J Am Chem Soc.</Emphasis> 2002;124:3661&#8211;3668.</td><td><a href=http://dx.doi.org/10.1021/ja012376y>10.1021/ja012376y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Meijler MM, Matsushita M, Wirsching P, Janda KD. Development of immunopharmacotherapy against drugs of abuse.<Emphasis Type="Italic">Curr Drug Discov Tech.</Emphasis> 2004;1:77&#8211;89.</td><td><a href=http://dx.doi.org/10.2174/1570163043484851>10.2174/1570163043484851</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Haney M, Kosten TR. Therapeutic vaccines for substance dependence.<Emphasis Type="Italic">Expert Rev Vaccines.</Emphasis> 2004;3:11&#8211;18.</td><td><a href=http://dx.doi.org/10.1586/14760584.3.1.11>10.1586/14760584.3.1.11</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Gorelick DA. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 1997;48:159&#8211;165.</td><td><a href=http://dx.doi.org/10.1016/S0376-8716(97)00119-1>10.1016/S0376-8716(97)00119-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Mattes CE, Belendiuk GW, Lynch TJ, Brady RO, Dretchen KL. Butyrylcholinesterase: an enzyme antidote for cocaine intoxication.<Emphasis Type="Italic">Addict Biol.</Emphasis> 1998;3:171&#8211;188.</td><td><a href=http://dx.doi.org/10.1080/13556219872236>10.1080/13556219872236</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Nachon F, Nicolet Y, Viquie N, Masson P, Fontecilla-Camps JD, Lockridge O. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.<Emphasis Type="Italic">Eur J Biochem.</Emphasis> 2002;269:630&#8211;637.</td><td><a href=http://dx.doi.org/10.1046/j.0014-2956.2001.02692.x>10.1046/j.0014-2956.2001.02692.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Mattes CE, Lynch TJ, Singh A, et al. Therapeutic use of butyrylcholinesterase for cocaine intoxication.<Emphasis Type="Italic">Toxicol Appl Pharmacol.</Emphasis> 1997;145:372&#8211;380.</td><td><a href=http://dx.doi.org/10.1006/taap.1997.8188>10.1006/taap.1997.8188</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Sun H, Pang Y-P, Lockridge O, Brimijoin S. Re-engineering butyrylcholinesterase as a cocaine hydrolase.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2002;62:220&#8211;224.</td><td><a href=http://dx.doi.org/10.1124/mol.62.2.220>10.1124/mol.62.2.220</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Larocca D, Burg MA, Jensen-Pergakes K, Ravey PE, Gonzales AM, Baird A. Evolving phage vectors for cell targeted gene delivery.<Emphasis Type="Italic">Curr Pharm Biotechnol.</Emphasis> 2002;3:45&#8211;57.</td><td><a href=http://dx.doi.org/10.2174/1389201023378490>10.2174/1389201023378490</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Smith GP. Filamentous fusion phage, novel expression vectors that display cloned antigens on the virion surface.<Emphasis Type="Italic">Science.</Emphasis> 1985;228:1315&#8211;1317.</td><td><a href=http://dx.doi.org/10.1126/science.4001944>10.1126/science.4001944</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Carlton RM. Phage therapy: past history and future prospects.<Emphasis Type="Italic">Arch Immunol Ther Exp (Warsz).</Emphasis> 1999;47:267&#8211;274.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Smith HW, Huggins RB. Successful treatment of experimental E coli infections in mice using phage: it general superiority over antibiotics.<Emphasis Type="Italic">J Gen Microbiol.</Emphasis> 1982;128:307&#8211;318.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1099/00221287-128-2-307>10.1099/00221287-128-2-307</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, VolumeID, Author_FamilyName_2, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowski A. Results in bacteriophage treatment of suppurative bacterial infections in the years 1981&#8211;1986.<Emphasis Type="Italic">Arch Immunol Ther Exp (Warsz).</Emphasis> 1986;35:569&#8211;583.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Stone R. Stalin&#8217;s forgotten cure.<Emphasis Type="Italic">Science.</Emphasis> 2002;298:728&#8211;731.</td><td><a href=http://dx.doi.org/10.1126/science.298.5594.728>10.1126/science.298.5594.728</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries.<Emphasis Type="Italic">Nature.</Emphasis> 1996;380:364&#8211;366.</td><td><a href=http://dx.doi.org/10.1038/380364a0>10.1038/380364a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Essler M, Ruoslahti E.. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculatures.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:2252&#8211;2257.</td><td><a href=http://dx.doi.org/10.1073/pnas.251687998>10.1073/pnas.251687998</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Dabrowska K., Switala-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A. Bacteriophage penetration in vertebrates.<Emphasis Type="Italic">J Appl Microbiol.</Emphasis> 2005;98:7&#8211;13.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2672.2004.02422.x>10.1111/j.1365-2672.2004.02422.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Frenkel D, Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:5675&#8211;5679.</td><td><a href=http://dx.doi.org/10.1073/pnas.072027199>10.1073/pnas.072027199</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Gao C, Mao S, Lo C-HL, Wirsching P, Lerner RA, Janda KD. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1999;96:6025&#8211;6030.</td><td><a href=http://dx.doi.org/10.1073/pnas.96.11.6025>10.1073/pnas.96.11.6025</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Gao C, Mao S, Kaufmann G, Wirsching P, Lerner RA, Janda KD. A method for the generation of combinatorial antibody libraries using pIX phage display.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:12612&#8211;12616.</td><td><a href=http://dx.doi.org/10.1073/pnas.192467999>10.1073/pnas.192467999</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Carrera MRA, Kaufmann GF, Mee JM, Meijler MM, Koob GF, Janda KD. Treating cocaine addiction with viruses.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2004;101:10416&#8211;10421.</td><td><a href=http://dx.doi.org/10.1073/pnas.0403795101>10.1073/pnas.0403795101</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibBook</td><td>Barbas CF, Burton DR, Scott JK, Silverman GJ.<Emphasis Type="Italic">Phage Display: A Laboratory Manual</Emphasis>: Tuebingen, Germany: Cold Spring Harbor Laboratory Press; 2001.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR58</td><td>BibChapter</td><td>Lyon M, Robbins TW. The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L, eds.,<Emphasis Type="Italic">Current Developments in Psychopharmacology</Emphasis>. vol. 4. New York: Spectrum; 1975:79&#8211;163.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/978-94-011-8123-5>10.1007/978-94-011-8123-5</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Illum L, Davis SS. Polymeric lamellar substrate particles for intranasal vaccination.<Emphasis Type="Italic">Adv Drug Deliv Res.</Emphasis> 2001;51:97&#8211;111.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(01)00171-5>10.1016/S0169-409X(01)00171-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Jones N. The nose and paranasal sinuses physiology and anatomy.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2001;51:5&#8211;19.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(01)00172-7>10.1016/S0169-409X(01)00172-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Bresler MM, Rosser SJ, Basran A, Bruce NC. Gene cloning and nucleotide sequencing and properties of a cocaine esterase from<Emphasis Type="Italic">Rhodococcus</Emphasis> sp strain MB1.<Emphasis Type="Italic">Appl Environ Microbiol.</Emphasis> 2000;66:904&#8211;908.</td><td><a href=http://dx.doi.org/10.1128/AEM.66.3.904-908.2000>10.1128/AEM.66.3.904-908.2000</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>